文献速递乳腺乳腺X线

深入探讨乳腺癌筛查:两种当代筛查策略的计算机模拟

Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
PubMed 文献 · AJR Am J Roentgenol · 2018-01-11

本研究采用蒙特卡罗计算机模拟,比较美国癌症协会2015年混合年度-双年度指南与美国预防服务工作组2016年固定双年度指南对平均风险女性乳腺X线筛查的获益与危害平衡。采用成本效果可接受曲线及每获得生命年假阳性筛查和 unnecessary 活检数分析,结果一般提示美国癌症协会2015年混合年度-双年度指南更受偏好;若假设乳腺X线筛查死亡获益降低,则不筛查可能合理。

要点

  • 混合年度-双年度筛查策略利用筛查期间获益与危害随年龄分布的不均匀性。
  • 模拟结果一般提示美国癌症协会2015年混合年度-双年度指南较美国预防服务工作组2016年固定双年度指南更受偏好。
  • 假设乳腺X线筛查死亡获益降低时,不筛查可能合理。

核心结论

  • 使用成本效果和临床指标的结果一般提示美国癌症协会2015年混合年度-双年度指南更受偏好;假设乳腺X线筛查死亡获益降低时,不筛查可能合理。

研究设计与样本

  • 蒙特卡罗计算机模拟,比较美国癌症协会2015年混合年度-双年度指南与美国预防服务工作组2016年固定双年度指南,对象为平均风险女性,采用成本效果可接受曲线及每获得生命年假阳性筛查和 unnecessary 活检数进行策略比较。

诊断标准与关键数值

  • 采用成本效果可接受曲线评估成本与健康结局评估中的不确定性,并在改变质量调整生命年支付意愿假设下检验策略偏好。
  • 采用每获得生命年假阳性筛查数和 unnecessary 活检数进行比较效果分析。
  • 在假设筛查死亡获益降低的替代情景下进行比较。

临床应用与阅片要点

  • 混合年度-双年度人群筛查策略利用了乳腺X线筛查获益与危害在筛查期间随年龄分布的不均匀性。
  • 该方法通过利用获益与危害随年龄累积的依赖性,代表改进指南的一步。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The debate over the value of screening mammography is rekindled with each new published study or guideline. Central to the discussion are the uncertainties about screening benefits and harms and the criteria used to assess them. Today, the magnitude of benefits for a population is less certain, and the evolving concept of harm has come to encompass false-positives (FPs), unnecessary biopsies, overdiagnosis, and overtreatment. This study uses a Monte Carlo computer simulation to study the balance of benefits and harms of mammographic breast cancer screening for average-risk women.

MATERIALS AND METHODS: This investigation compares the American Cancer Society's 2015 mixed annual-biennial guideline with the U.S. Preventive Services Task Force's 2016 fixed biennial guideline. Screening strategies are compared using cost-effectiveness acceptability curves, an economic analysis describing uncertainty in evaluating costs and health outcomes. Strategy preference is examined under changing assumptions of willingness to pay for a quality-adjusted life-year. Additionally, comparative effectiveness analysis is performed using FP screens and unnecessary biopsies per life-year gained. Alternative scenarios are compared assuming a reduced mortality benefit of screening.

RESULTS: In general, results using both cost-effectiveness and clinical measures indicate that American Cancer Society's 2015 mixed annual-biennial guideline is preferred. Assuming decreases in the mortality benefit of mammography, no screening may be reasonable.

CONCLUSION: The use of a mixed annual-biennial strategy for population screening takes advantage of the nonuniformity of occurrence of mammography benefits and harms over the duration of screening. This approach represents a step toward improving guidelines by exploiting age dependencies at which benefits and harms accrue.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Carter KJ, Castro F, Morcos RN, et al. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies. AJR Am J Roentgenol. 2018. PMID: 29323554. doi:10.2214/AJR.17.18484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。